title: High-performance liquid chromatographic determination of 3 alpha,5 beta-tetrahydroaldosterone in human urine with chemiluminescence detection.
abstract: A sensitive method for the determination of 3 alpha,5 beta-tetrahydroaldosterone (THALD) in human urine is described. The method uses high-performance liquid chromatography with chemiluminescence detection. Urinary THALD, released by enzyme hydrolysis, is isolated and concentrated using a Sephadex G-25M column and Bond-Elut C1 cartridges, and then oxidized by copper(II) acetate to form the corresponding glyoxal derivative. The glyoxal derivative is converted into the chemiluminescent quinoxaline by reaction with 4,5-diaminophthalhydrazide. The chemiluminescent quinoxaline is separated within 50 min on a reversed-phase column (TSKgel ODS-120T) with isocratic elution, followed by chemiluminescence detection; the chemiluminescence is produced by the reaction of the quinoxaline with hydrogen peroxide in the presence of potassium hexacyanoferrate(III) in alkaline solution. The detection limit for THALD is 0.6 pmol (220 pg) ml-1 in urine [1.5 fmol (0.53 pg) per 20 microliters injection] at a signal-to-noise ratio of 3. This method permits the sensitive and precise determination of THALD in human urine (50 microliters) from normal subjects and a patient with primary aldosteronism.
authors: Faculty of Pharmaceutical Sciences, Fukuoka University, Japan.
authors: J
authors: J
authors: Ishida
authors: S
authors: S
authors: Sonezaki
authors: M
authors: M
authors: Yamaguchi
authors: T
authors: T
authors: Yoshitake
mesh_terms: D000450:Aldosterone / Q000031:analogs & derivatives* / Q000652:urine; D002851:Chromatography, High Pressure Liquid / Q000379:methods* / Q000706:statistics & numerical data; D006037:Glyoxal; D006801:Humans; D006861:Hydrogen Peroxide; D006929:Hyperaldosteronism / Q000652:urine; D007202:Indicators and Reagents; D008163:Luminescent Measurements; D010793:Phthalazines; D011786:Quality Control; D011810:Quinoxalines
chemical_list: D007202:Indicators and Reagents; D010793:Phthalazines; D011810:Quinoxalines; C013282:tetrahydroaldosterone; D000450:Aldosterone; D006037:Glyoxal; C067545:4,5-diaminophthalhydrazide; D006861:Hydrogen Peroxide